Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study

BACKGROUND: The SARS-CoV-2 omicron (B.1.1.529) variant, which was first identified in November, 2021, spread rapidly in many countries, with a spike protein highly diverged from previously known variants, and raised concerns that this variant might evade neutralising antibody responses. We therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheward, Daniel J, Kim, Changil, Ehling, Roy A, Pankow, Alec, Castro Dopico, Xaquin, Dyrdak, Robert, Martin, Darren P, Reddy, Sai T, Dillner, Joakim, Karlsson Hedestam, Gunilla B, Albert, Jan, Murrell, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930016/
https://www.ncbi.nlm.nih.gov/pubmed/35305699
http://dx.doi.org/10.1016/S1473-3099(22)00129-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930016/
https://www.ncbi.nlm.nih.gov/pubmed/35305699
http://dx.doi.org/10.1016/S1473-3099(22)00129-3

Ejemplares similares